Welcome to our dedicated page for NORTHROP GRUMMAN /DE/ SEC filings (Ticker: NOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NORTHROP GRUMMAN /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NORTHROP GRUMMAN /DE/'s regulatory disclosures and financial reporting.
Northrop Grumman Corp ownership filing shows Vanguard Capital Management beneficially owned 10,248,540 shares of Common Stock, representing 7.22% of the class as of 03/31/2026. The filing reports sole dispositive power over 10,248,540 shares and sole voting power for 1,299,313 shares. The disclosure attributes holdings to Vanguard Capital Management and specified Vanguard affiliates and notes these include securities held by Vanguard funds and managed accounts.
Northrop Grumman Corporation registered a shelf on Form S-3 to offer senior debt securities and common stock. The prospectus dated April 21, 2026 describes a shelf registration permitting sales from time to time, with specific terms and amounts to be provided in prospectus supplements.
The prospectus states proceeds will be used for general corporate purposes, including repayment of debt, share repurchases, working capital, capital expenditures and acquisitions. The filing incorporates by reference the company’s recent SEC reports and identifies The Bank of New York Mellon as indenture trustee for senior debt.
Northrop Grumman’s first quarter 2026 results show sharply higher profitability on modest sales growth. Sales rose 4% to $9.9 billion, while operating income jumped to $989 million from $573 million as operating margin expanded to 10.0% from 6.1%.
Net earnings increased 82% to $875 million and diluted EPS climbed to $6.14 from $3.32, helped by the absence of the large B‑21 loss charge recorded a year earlier and stronger segment performance, particularly in Aeronautics and Mission Systems.
Backlog remained very strong at $95.6 billion, with about 60% expected to turn into revenue within 24 months. Free cash flow was negative $1.8 billion, reflecting typical first‑half working capital usage and continued investment, including capacity expansion on the B‑21 program.
Northrop Grumman reported strong first quarter 2026 results, with sales up 4% to $9.9 billion and diluted EPS up 85% to $6.14. Net earnings rose 82% to $875 million, driven mainly by much higher operating income and pension benefits versus last year’s B‑21 loss provision.
Segment operating income nearly doubled, lifting the segment margin from 6.0% to 10.8%, led by Aeronautics Systems and Mission Systems. Space Systems saw lower sales and margins due to the NGI wind‑down and a $71 million GEM 63XL charge. Free cash flow was a use of $1.8 billion, similar to last year, reflecting typical first‑half working capital timing. The company ended the quarter with $95.6 billion of backlog and reaffirmed its 2026 guidance for sales, segment operating income, MTM‑adjusted EPS and free cash flow.
Northrop Grumman Corporation is asking shareholders to vote at its 2026 virtual annual meeting on 11 director nominees, executive pay, auditor ratification, and a shareholder proposal for an independent board chair, which the Board recommends voting against.
For 2025, sales rose 2% to $42 billion, with organic sales up 3% and operating margin reaching 10.8%. Diluted EPS was $29.08, with mark-to-market adjusted EPS of $26.34, exceeding guidance. The company ended 2025 with record backlog of $95.7 billion and generated $4.8 billion in operating cash flow and $3.3 billion in free cash flow, while increasing its quarterly dividend by 12%.
The proxy emphasizes strong board independence (about 92% independent directors), a lead independent director with extensive responsibilities, proxy access rights, and majority voting for directors. Executive compensation is heavily performance-based, with over 80% variable pay and non-financial metrics tied to customers, people, and environmental sustainability.
Northrop Grumman director Marianne Catherine Brown reported acquiring 68 shares of common stock valued at $682.24 per share on a deferred basis. The shares were credited to a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. Following this award, she holds 11,066 shares of common stock, including dividends, in the stock unit account pursuant to the plan. This reflects routine equity-based compensation rather than an open‑market stock purchase.
Northrop Grumman director Arvind Krishna reported an acquisition of 53 shares of common stock, valued at $682.24 per share, as a grant deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan. Following this compensation-related award, Krishna directly holds 2,317 shares of common stock.
Northrop Grumman Corp: Amendment to Schedule 13G/A by The Vanguard Group reporting zero beneficial ownership.
The filing states that following an internal realignment on January 12, 2026, certain Vanguard subsidiaries will report holdings separately under SEC Release No. 34-39538. The Schedule 13G/A shows Amount beneficially owned: 0 and Percent of class: 0%, and identifies Vanguard signing through Ashley Grim on 03/27/2026.